TechGROWTH Ohio portfolio company OsteoDx receives $2M grant from the National Institutes of Health
TechGROWTH Ohio portfolio company OsteoDx receives $2M grant from the National Institutes of Health Published: May 19, 2021 Author: Staff reports OsteoDx Inc., a TechGROWTH Ohio portfolio company, has been selected for funding through a Small Business Innovation Research (SBIR) Phase II grant with the National Institutes of Health. The grant will provide $2M in support of a multicenter study to further measure and validate the efficacy of the company’s proprietary Cortical Bone Mechanics Technology (CBMT), designed to identify patients at risk of fracture due to osteoporosis...